BETHESDA, Md., Jan. 5, 2011 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its President, Dr. Robert Lodder, will be presenting at both OneMedForum SF 2011 and Biotech Showcase 2011.
Dr. Lodder will deliver the Company's corporate presentation at two upcoming prestigious finance conferences to be held in San Francisco, CA, next week. Ms. Leisa Dennehy, Commercial and Corporate Development Advisor, will be attending the convention with Dr. Lodder and will be leading the business development activities for Spherix.
At OneMedForum SF 2011, a select group of emerging growth biotech, medtech and healthcare IT companies will present at the conference to institutional healthcare investors. The conference is designed to connect these select companies, including Spherix, with new sources of capital.
Biotech Showcase provides private and public life science companies the opportunity to present to an audience of investors and business development executives during the course of the world's largest annual healthcare investor conference.
Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experi
|SOURCE Spherix Incorporated|
Copyright©2010 PR Newswire.
All rights reserved